<VariationArchive VariationID="505425" VariationName="NM_181458.4(PAX3):c.879dup (p.Phe294fs)" VariationType="Duplication" Accession="VCV000505425" Version="12" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-02-14" DateCreated="2018-04-09" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="496265" VariationID="505425">
      <GeneList>
        <Gene Symbol="PAX3" FullName="paired box 3" GeneID="5077" HGNC_ID="HGNC:8617" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2q36.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="222199887" stop="222298998" display_start="222199887" display_stop="222298998" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="223064605" stop="223163714" display_start="223064605" display_stop="223163714" Strand="-" />
          </Location>
          <OMIM>606597</OMIM>
          <Haploinsufficiency last_evaluated="2020-05-27" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=PAX3">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-05-27" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=PAX3">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_181458.4(PAX3):c.879dup (p.Phe294fs)</Name>
      <CanonicalSPDI>NC_000002.12:222221300:CCCCCC:CCCCCCC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>2q36.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="222221300" stop="222221301" display_start="222221300" display_stop="222221301" variantLength="1" positionVCF="222221300" referenceAlleleVCF="A" alternateAlleleVCF="AC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="223086019" stop="223086020" display_start="223086019" display_stop="223086020" variantLength="1" positionVCF="223086019" referenceAlleleVCF="A" alternateAlleleVCF="AC" />
      </Location>
      <OtherNameList>
        <Name>NM_001127366.2:c.876dupG</Name>
        <Name>p.Phe293ValfsX116</Name>
      </OtherNameList>
      <ProteinChange>F294fs</ProteinChange>
      <ProteinChange>F293fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.223086025dup" Assembly="GRCh37">
            <Expression>NC_000002.11:g.223086025dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.222221306dup" Assembly="GRCh38">
            <Expression>NC_000002.12:g.222221306dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011632.1" sequenceAccession="NG_011632" sequenceVersion="1" change="g.82681dup">
            <Expression>NG_011632.1:g.82681dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001127366.3" sequenceAccession="NM_001127366" sequenceVersion="3" change="c.876dup">
            <Expression>NM_001127366.3:c.876dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001120838.1" sequenceAccession="NP_001120838" sequenceVersion="1" change="p.Phe293fs">
            <Expression>NP_001120838.1:p.Phe293fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_181457.4" sequenceAccession="NM_181457" sequenceVersion="4" change="c.879dup">
            <Expression>NM_181457.4:c.879dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_852122.1" sequenceAccession="NP_852122" sequenceVersion="1" change="p.Phe294fs">
            <Expression>NP_852122.1:p.Phe294fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_181458.4" sequenceAccession="NM_181458" sequenceVersion="4" change="c.879dup" MANESelect="true">
            <Expression>NM_181458.4:c.879dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_852123.1" sequenceAccession="NP_852123" sequenceVersion="1" change="p.Phe294fs">
            <Expression>NP_852123.1:p.Phe294fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_181459.4" sequenceAccession="NM_181459" sequenceVersion="4" change="c.879dup">
            <Expression>NM_181459.4:c.879dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_852124.1" sequenceAccession="NP_852124" sequenceVersion="1" change="p.Phe294fs">
            <Expression>NP_852124.1:p.Phe294fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_181460.4" sequenceAccession="NM_181460" sequenceVersion="4" change="c.879dup">
            <Expression>NM_181460.4:c.879dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_852125.1" sequenceAccession="NP_852125" sequenceVersion="1" change="p.Phe294fs">
            <Expression>NP_852125.1:p.Phe294fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_181461.4" sequenceAccession="NM_181461" sequenceVersion="4" change="c.879dup">
            <Expression>NM_181461.4:c.879dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_852126.1" sequenceAccession="NP_852126" sequenceVersion="1" change="p.Phe294fs">
            <Expression>NP_852126.1:p.Phe294fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA539836815" DB="ClinGen" />
        <XRef Type="rs" ID="1553572967" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_181458.4(PAX3):c.879dup (p.Phe294fs) AND multiple conditions" Accession="RCV000616546" Version="4">
        <ClassifiedConditionList TraitSetID="48396">
          <ClassifiedCondition DB="MedGen" ID="C5680250">Rare genetic deafness</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C3266898">Waardenburg syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2016-11-08" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_181458.4(PAX3):c.879dup (p.Phe294fs) AND Waardenburg syndrome type 1" Accession="RCV000987039" Version="1">
        <ClassifiedConditionList TraitSetID="1162">
          <ClassifiedCondition DB="MedGen" ID="C1847800">Waardenburg syndrome type 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-05-28" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_181458.4(PAX3):c.879dup (p.Phe294fs) AND not provided" Accession="RCV001854141" Version="5">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-09-19" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-09-19" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2018-04-09" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">8533800</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">8589691</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9017978</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1162" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4496" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">WAARDENBURG SYNDROME WITH DYSTOPIA CANTHORUM</ElementValue>
                <XRef Type="MIM" ID="193500" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Waardenburg syndrome type 1</ElementValue>
                <XRef ID="Waardenburg+syndrome+type+1/7424" DB="Genetic Alliance" />
                <XRef ID="MONDO:0008670" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Waardenburg's syndrome type 1</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">PAX3</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">WS1</ElementValue>
                <XRef Type="MIM" ID="193500" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Waardenburg syndrome type I (WS1) is an auditory-pigmentary disorder comprising congenital sensorineural hearing loss and pigmentary disturbances of the iris, hair, and skin along with dystopia canthorum (lateral displacement of the inner canthi). The hearing loss in WS1, observed in approximately 60% of affected individuals, is congenital, typically non-progressive, either unilateral or bilateral, and sensorineural. Most commonly, hearing loss in WS1 is bilateral and profound (&gt;100 dB). The majority of individuals with WS1 have either a white forelock or early graying of the scalp hair before age 30 years. The classic white forelock observed in approximately 45% of individuals is the most common hair pigmentation anomaly seen in WS1. Affected individuals may have complete heterochromia iridium, partial/segmental heterochromia, or hypoplastic or brilliant blue irides. Congenital leukoderma is frequently seen on the face, trunk, or limbs.</Attribute>
                <XRef ID="NBK1531" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5519" />
                <XRef ID="5519" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301703</ID>
                <ID Source="BookShelf">NBK1531</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2002">
                <ID Source="pmc">3110944</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2014">
                <ID Source="PubMed">24651602</ID>
              </Citation>
              <XRef ID="894" DB="Orphanet" />
              <XRef ID="C1847800" DB="MedGen" />
              <XRef ID="MONDO:0008670" DB="MONDO" />
              <XRef Type="MIM" ID="193500" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="48396" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="7993" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Waardenburg's syndrome</ElementValue>
                <XRef ID="47434006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Waardenburg syndrome</ElementValue>
                <XRef ID="MONDO:0018094" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS193500" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Van der Hoeve Halbertsma Waardenburg Gualdi Syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ptosis-Epicanthus Syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mende Syndrome</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5525" />
                <XRef ID="5525" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="general" Abbrev="ACMG, 2002">
                <ID Source="pmc">3110944</ID>
              </Citation>
              <XRef ID="3440" DB="Orphanet" />
              <XRef ID="C3266898" DB="MedGen" />
              <XRef ID="MONDO:0018094" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS193500" DB="OMIM" />
            </Trait>
            <Trait ID="38576" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Rare genetic deafness</ElementValue>
                <XRef ID="96210" DB="Orphanet" />
              </Name>
              <XRef ID="96210" DB="Orphanet" />
              <XRef ID="C5680250" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1393728" SubmissionDate="2019-03-21" DateLastUpdated="2018-04-09" DateCreated="2018-04-09">
        <ClinVarSubmissionID localKey="72278725|Orphanet:ORPHA96210;ORPHA3440" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000712622" DateUpdated="2018-04-09" DateCreated="2018-04-09" Type="SCV" Version="2" SubmitterName="Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine" OrgID="21766" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-11-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">8533800</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">8589691</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9017978</ID>
          </Citation>
          <Comment>The p.Phe293fs variant in PAX3 has been reported in 4 individuals with Waardenbu rg syndrome type I (Baldwin 1995, Tassabehji 1995, Morell 1997), and segregated with disease in 3 affected relatives from 2 families (Baldwin 1995, Morell 1997) . It has not been identified in large population studies. This variant is predic ted to cause a frameshift, which alters the protein?s amino acid sequence beginn ing at position 293 and leads to a premature termination codon 116 amino acids d ownstream. This alteration is then predicted to lead to a truncated or absent pr otein. Heterozygous loss of function of the PAX3 gene is an established disease mechanism in individuals with Waardenburg syndrome. In summary, this variant mee ts criteria to be classified as pathogenic for Waardenburg syndrome in an autoso mal dominant manner based upon its predicted impact to the protein, presence in multiple previously reported affected individuals, co-segregations, and extremel y low frequency in the general population.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LMM Criteria</Attribute>
          <Citation>
            <ID Source="PubMed">24033266</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>not provided</AffectedStatus>
              <FamilyData NumFamiliesWithVariant="1" />
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PAX3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_001127366.2:EXON 6</GeneLocation>
          </Location>
          <OtherNameList>
            <Name>NM_001127366.2:c.876dupG</Name>
            <Name>p.Phe293ValfsX116</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000002.11:g.223086019_223086020insC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="Orphanet" ID="ORPHA96210" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="Orphanet" ID="ORPHA3440" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5348979</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2242026" SubmissionDate="2019-10-22" DateLastUpdated="2020-01-09" DateCreated="2020-01-09">
        <ClinVarSubmissionID localKey="NC_000002.11:g.223086019_223086020insC|OMIM:193500" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001136227" DateUpdated="2020-01-09" DateCreated="2020-01-09" Type="SCV" Version="1" SubmitterName="Mendelics" OrgID="500035" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-05-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Mendelics Assertion Criteria 2017</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/chhjzatu/mendelics_assertion_criteria_2017.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PAX3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000002.11:g.223086019_223086020insC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="193500" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>MENDELICS_CLINVAR_020</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4244673" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="4838830|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002223326" DateUpdated="2024-02-14" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-09-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">8533800</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">8589691</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9017978</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 505425). This variant is also known as 874ins(G). This premature translational stop signal has been observed in individual(s) with Waardenburg syndrome (PMID: 8533800, 8589691, 9017978; Invitae). In at least one individual the variant was observed to be de novo. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Phe294Valfs*116) in the PAX3 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 186 amino acid(s) of the PAX3 protein.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PAX3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000002.11:g.223086019_223086020insC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1393728" TraitType="Disease" MappingType="XRef" MappingValue="ORPHA3440" MappingRef="Orphanet">
        <MedGen CUI="C3266898" Name="Waardenburg syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2242026" TraitType="Disease" MappingType="XRef" MappingValue="193500" MappingRef="OMIM">
        <MedGen CUI="C1847800" Name="Waardenburg syndrome type 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1393728" TraitType="Disease" MappingType="XRef" MappingValue="ORPHA96210" MappingRef="Orphanet">
        <MedGen CUI="C5680250" Name="Rare genetic deafness" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4244673" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

